The median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of market to a certain extent.
The global in vitro fertilization market is projected to be valued at USD 465.2 Million in 2016 and is expected to grow at a CAGR of 10.9% from 2017 to reach to USD 847.8 Million by 2022.
Objectives of the Study:
- To define, describe, and forecast the global in vitro fertilization market with respect to type of cycle, product, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape of market leaders
- To forecast the size of the global market with respect to four main regions—North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
- To profile the key players in the global market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as agreements and partnerships, mergers, acquisitions, reprocessed medical device developments, and service launches of the leading players in the in vitro fertilization market
To know about the assumptions considered for the study, download the pdf brochure
The major players in the in vitro fertilization market include CooperSurgical (US), Vitrolife (Sweden), Cook Medical (US), Irvine Scientific (US), and Thermo Fisher Scientific (US).
Target Audience:
- In vitro fertilization manufacturers
- In vitro fertilization distributors
- Healthcare institutions (hospitals, clinics, cryobanks)
- Research institutes
- Vendors/service providers
Geographically, the in vitro fertilization market in Asia Pacific accounts for the largest share of the global market, followed by Europe. The large share and high growth rate of the APAC region can be attributed growth in the median age of first-time motherhood, rising infertility rates, growing prevalence of PCOS, increasing incidence of obesity, rise in fertility tourism, and government initiatives.
However, the high cost of the procedure and restrictive regulations and ethical concerns is likely to restrain the growth of the market during the forecast period.
Read full information – https://www.marketsandmarkets.com/Market-Reports/in-vitro-fertilization-market-89198891.html
